Atossa Pharma (ATOS) Cash Funds Calculated per Share

Symbol and logo of brand Atossa Pharma (ATOS)

Atossa Therapeutics (ATOS) monetizes proprietary breast cancer treatments leveraging patent protection. This chart of cash per share illustrates the market response, where the latest parameter is 2.08. Production risks are minimized through the use of external CDMO facilities. Capital stability ensures independence from macroeconomic trends, transforming the company into a reliable defensive asset for investors.

Atossa Therapeutics Inc (ATOS): Cash per Single Share from 07/04/2022 to 11/20/2026

Comprehensive metric breakdowns and analytics for Atossa Therapeutics, Inc. (ATOS)

- market value and analyst target forecast:
- cash and cash flow data:
Summary company analysis:ATOS (Atossa Pharma)
Finished products of atossatherapeutics.com

This indicator determines the actual financial cushion by calculating the share of confirmed cash per common share to assess liquidity. Analyzing the free liquidity per share reveals whether the existing capital of Atossa Therapeutics (ATOS) is sufficient to fund costly, multi-year clinical trials involving scientists, despite the automation of drug production.